Author
Number of items: 117.
2025
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy : A clinical consensus statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care (ACVC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy and the European Association for Haemophilia and Allied Disorders (EAHAD). (2025)
Dan Atar,
Christophe Vandenbriele,
Stefan Agewall,
Bruna Gigante,
Andreas Goette,
Diana A Gorog,
Pål A Holme,
Konstantin A Krychtiuk,
Bianca Rocca,
Jolanta M Siller-Matula,
Marco Valgimigli,
Andrea Rubboli
and
Robert Klamroth
![]()
Editorial: Precision medicine: biomarker testing for diagnosis and treatment of cardiovascular disease. (2025)
Hendrianus Hendrianus,
Eliano Navasere,
Diana Gorog,
Paul A. Gurbel,
Sang-Wook Kim
and
Young-Hoon Jeong
![]()
Current and novel biomarkers in cardiogenic shock. (2025)
Victor Galusko,
Florian A. Wenzl,
Christophe Vandenbriele,
Vasileios Panoulas,
Thomas F. Lüscher
and
Diana A. Gorog
![]()
Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators’ viewpoint. (2025)
Jacek Kubica,
Piotr Adamski,
Robert Gajda,
Aldona Kubica,
Małgorzata Ostrowska,
Gavino Casu,
Diana Gorog,
Paul Gurbel,
Tomasz Hajdukiewicz,
Miłosz Jaguszewski,
Young-Hoon Jeong,
Agata Kosobucka-Ozdoba,
Zuzana Motovska,
Piotr Niezgoda,
Maciej Piasecki,
Przemysław Podhajski,
Paolo Raggi,
Uzeyir Rahimov,
Jolanta Siller-Matula,
Grzegorz Skonieczny,
Łukasz Szarpak,
Paweł Szymański,
Udaya Tantry
and
Eliano Navarese
![]()
2024
Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters. (2024)
Diana A Gorog
![]()
Impaired endogenous fibrinolysis status: a potential prognostic predictor in ischemic stroke. (2024)
Yang Chen,
Ying Gue,
Garry Mcdowell,
Diana Gorog
and
Gregory Y H Lip
![]()
Antithrombotic management during percutaneous mechanical circulatory support - defining the status quo, before agreeing quo vadis. (2024)
Diana Gorog
and
Alain Combes
![]()
Tissue factor pathway inhibitor and interleukin-1 receptor levels in COVID-19. (2024)
Diana Gorog
and
Brijesh Patel
![]()
Inflammation and platelet reactivity during adjunctive colchicine versus aspirin in patients with acute coronary syndrome treated with potent P2Y12 inhibitor. (2024)
Seung-Yul Lee,
Jae Young Cho,
Diana A. Gorog,
Dominick J. Angiolillo,
Kyeong Ho Yun,
Jong-Hwa Ahn,
Jin-Sin Koh,
Yongwhi Park,
Seok-Jae Hwang,
Jin-Yong Hwang,
Jin Won Kim,
Yangsoo Jang
and
Young-Hoon Jeong
![]()
Impact of Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy on Endogenous Fibrinolysis in Acute Coronary Syndrome: The VaLiDate-R study. (2024)
Ying X. Gue,
Vassilios Memtsas,
Rahim Kanji,
David Wellsted,
Amanda Busby,
Megan Smith,
Enric Vilar,
Alisdair Ryding,
Deepa J. Arachchillage
and
Diana Gorog
![]()
Spontaneous Reperfusion in STEMI: its mechanisms and possible modulation. (2024)
Joshua Leader,
Rahim Kanji
and
Diana Gorog
![]()
2023
Global Thrombosis Test: Occlusion Is Attributable to Shear-Induced Platelet Thrombus Formation. (2023)
Diana Gorog
and
Junichiro Yamamoto
![]()
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events Comparing East Asians With Westerners: A Meta-Analysis. (2023)
Rock Bum Kim,
Ang Li,
Ki-Soo Park,
Yune-Sik Kang,
Jang-Rak Kim,
Eliano P Navarese,
Diana Gorog,
Udaya S. Tantry,
Paul A Gurbel,
Jin-Yong Hwang,
Oh-Young Kwon
and
Young-Hoon Jeong
![]()
P2Y12 Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot Study. (2023)
Seung-Yul Lee,
Young-Hoon Jeong,
Kyeong Ho Yun,
Jae Young Cho,
Diana Gorog,
Dominick J. Angiolillo,
Kim Jin Won
and
Yangsoo Jang
![]()
Measuring thrombus stability at high shear, together with thrombus formation and endogenous fibrinolysis: first experience using the Global Thrombosis Test 3 (GTT-3). (2023)
Rahim Kanji,
Joshua Leader,
Vassilios Memtsas
and
Diana Gorog
![]()
Anticoagulation in the ICU: a future for contact pathway inhibition? (2023)
Charlotte J Van Edom,
Diana Gorog
and
Christophe Vandenbriele
![]()
Is There Long-Term Clinical Equipoise Between CABG and PCI for Isolated Left Anterior Descending Artery Disease? (2023)
Eliano P. Navarese,
Eleonora Ruscio
and
Diana A. Gorog
![]()
Management of Bleeding and Hemolysis During Percutaneous Microaxial Flow Pump Support A Practical Approach. (2023)
Charlotte J. Van Edom,
Mario Gramegna,
Luca Baldetti,
Alessandro Beneduce,
Thomas Castelein,
Dieter Dauwe,
Pascal Frederiks,
Gennaro Giustino,
Marc Jacquemin,
Stefan P. Janssens,
Vasileios F. Panoulas,
Janine Pöss,
Alexander Rosenberg,
Hannah A.I. Schaubroeck,
Benedikt Schrage,
Guido Tavazzi,
Thomas Vanassche,
Leen Vercaemst,
Dirk Vlasselaers,
Pascal Vranckx,
Jan Belohlavek,
Diana A. Gorog,
Kurt Huber,
Alexandre Mebazaa,
Bart Meyns,
Federico Pappalardo,
Anna M. Scandroglio,
Gregg W. Stone,
Dirk Westermann,
Alaide Chieffo,
Susanna Price
and
Christophe Vandenbriele
![]()
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis. (2023)
Diana Gorog,
Jose Luis Ferreiro,
Ingo Ahrens,
Junya Ako,
Tobias Geisler,
Sigrun Halvorsen,
Kurt Huber,
Young-Hoon Jeong,
Eliano P Navarese,
Andrea Rubboli,
Dirk Sibbing,
Jolanta M Siller-Matula,
Robert F. Storey,
Jack W C Tan,
Jurrien M.ten Berg,
Marco Valgimigli,
Christophe Vandenbriele
and
Gregory Y H Lip
![]()
Recommendation on the nomenclature for anticoagulants: updated communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Commitee on the Control of Anticoagulation. (2023)
Geoffrey D Barnes,
Walter Ageno,
Lana A Castellucci,
Thita Chiasakul,
Renee Eslick,
Jose Luis Ferreiro,
David Gailani,
Diana Gorog,
Gregory Y H Lip,
Leslie Raffini,
Suely M Rezende,
Jeffrey I Weitz
and
Adam Cuker
![]()
Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction. (2023)
Rahim Kanji,
Ying X. Gue,
Vassilios Memtsas,
Neil H. Spencer
and
Diana Gorog
![]()
Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction. (2023)
Seung Hun Lee,
Hyun Kuk Kim,
Jong-Hwa Ahn,
Min Gyu Kang,
Kye-Hwan Kim,
Jae Seok Bae,
Sang Young Cho,
Jin-Sin Koh,
Yongwhi Park,
Seok Jae Hwang,
Diana Gorog,
Udaya S. Tantry,
Kevin P. Bliden,
Paul A Gurbel,
Jin-Yong Hwang
and
Young-Hoon Jeong
![]()
Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis. (2023)
Diana Gorog,
Visvesh Jeyalan,
Rafaella I. L. Markides,
Eliano P Navarese,
Young-Hoon Jeong
and
Mohamed Farag
![]()
PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection. (2023)
Eliano P. Navarese,
Przemysław Podhajski,
Paul A. Gurbel,
Klaudyna Grzelakowska,
Eleonora Ruscio,
Udaya Tantry,
Przemysław Magielski,
Aldona Kubica,
Piotr Niezgoda,
Piotr Adamski,
Roman Junik,
Grzegorz Przybylski,
Marta Pilaczyńska-Cemel,
Manali Rupji,
Giuseppe Specchia,
Jarosław Pinkas,
Robert Gajda,
Diana A. Gorog,
Felicita Andreotti
and
Jacek Kubica
![]()
2022
Effect of Remote Ischaemic Conditioning on the inflammatory cytokine cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial. (2022)
Kishal Lukhna,
Helison R. P. do Carmo,
Alejandro Rossell Castillo,
Sean M. Davidson,
Hayli Geffen,
Sara Giesz,
Pelin Golforoush,
Ticiane Gonçalez Bovi,
Diana Gorog,
Alan Salama,
Aqeela Imamdin,
Siavash Kalkhoran,
Sandrine Lecour,
Mauricio W. Perroud Jr.,
Mpiko Ntsekhe,
Andrei C. Sposito
and
Derek M. Yellon
![]()
Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction. (2022)
Rahim Kanji,
Ying X. Gue,
Mohamed F. Farag,
Neil H. Spencer,
Nicola J. Mutch
and
Diana A. Gorog
![]()
Reduction or de-escalation of dual antiplatelet therapy intensity or duration in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A mini-review. (2022)
Mohamed Farag,
Visvesh Jeyalan,
Jose Luis Ferreiro,
Young-Hoon Jeong,
Tobias Geisler
and
Diana A. Gorog
![]()
Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients? (2022)
Ying X. Gue,
Diana A. Gorog
and
Gregory Y.H. Lip
![]()
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. (2022)
Diana A. Gorog,
Robert F. Storey,
Paul A. Gurbel,
Udaya S. Tantry,
Jeffrey S. Berger,
Mark Y. Chan,
Daniel Duerschmied,
Susan S. Smyth,
William A.E. Parker,
Ramzi A. Ajjan,
Gemma Vilahur,
Lina Badimon,
Jurrien M.ten Berg,
Hugo ten Cate,
Flora Peyvandi,
Taia T. Wang
and
Richard C. Becker
![]()
Antithrombotic in atrial fibrillation and coronary artery disease – Does less mean more? (2022)
Ying X. Gue,
Diana Gorog
and
Gregory Y H Lip
![]()
Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock JACC Review Topic of the Week. (2022)
Christophe Vandenbriele,
Deepa J. Arachchillage,
Pascal Frederiks,
Gennaro Giustino,
Diana A. Gorog,
Mario Gramegna,
Stefan Janssens,
Bart Meyns,
Amin Polzin,
Mara Scandroglio,
Benedikt Schrage,
Gregg W. Stone,
Guido Tavazzi,
Thomas Vanassche,
Pascal Vranckx,
Dirk Westermann,
Susanna Price
and
Alaide Chieffo
![]()
Multicenter, Randomized, Active Comparator-Controlled, Double-Blind, Double-Dummy, Parallel Group, Dose-Finding Phase 2 Study Comparing the Safety of the Oral FXIa Inhibitor Asundexian with Apixaban in Patients with Atrial Fibrillation. (2022)
Jonathan P Piccini,
Valeria Caso,
Stuart J Connolly,
Keith A A Fox,
Jonas Oldgren,
Schuyler Jones,
Diana Gorog,
Vaclav Durdil,
Thomas Viethen,
Christoph Neumann,
Hardi Mundl
and
Manesh R Patel
![]()
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: An European and Asia-Pacific Expert Consensus Paper. (2022)
Diana Gorog,
Ying X. Gue,
Tze-Fan Chao,
Laurent Fauchier,
Jose Luis Ferreiro,
Kurt Huber,
Stavros V Konstantinidis,
Deirdre A Lane,
Francisco Marin,
Jonas Oldgren,
Tatjana Potpara,
Vanessa Roldan,
Andrea Rubboli,
Dirk Sibbing,
Hung-Fat Tse,
Gemma Vilahur
and
Gregory Y H Lip
![]()
NETs in the infarct-related coronary artery – a marker or mediator of adverse outcome? (2022)
Diana Gorog
and
Steffen Massberg
![]()
2021
Influence of Hypercoagulability and Impaired Fibrinolysis on Occurrence of Acute Myocardial Infarction and Prognostic Implication Following Percutaneous Coronary Intervention. (2021)
Hyun Kuk Kim,
Seung Hun Lee,
Jong-Hwa Ahn,
Min Gyu Kang,
Kye-Hwan Kim,
Jae Seok Bae,
Sang Young Cho,
Jin-Sin Koh,
Yongwhi Park,
Seok Jae Hwang,
Diana Gorog,
Udaya S. Tantry,
Paul A Gurbel,
Jin-Yong Hwang
and
Young-Hoon Jeong
![]()
When a meta-analysis equals a single large-scale trial with meaningful follow-up. (2021)
Eliano P Navarese,
Dean Kereiakes,
Diana Gorog,
Alexandra Lansky
and
Felicita Andreotti
![]()
Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial. (2021)
Jacek Kubica,
Piotr Adamski,
Diana A. Gorog,
Aldona Kubica,
Bernd Jilma,
Andrzej Budaj,
Jolanta M. Siller-Matula,
Paul A. Gurbel,
Dimitrios Alexopoulos,
Jolita Badarienė,
Paweł Dąbrowski,
Dariusz Dudek,
Evangelos Giannitsis,
Grzegorz Horszczaruk,
Miłosz J. Jaguszewski,
Stefan James,
Young Hoon Jeong,
Michał Kryjak,
Piotr Niezgoda,
Małgorzata Ostrowska,
Giuseppe Patti,
Janusz Romanek,
Salvatore Di Somma,
Giuseppe Specchia,
Udaya Tantry,
Mariusz Gąsior,
Agnieszka Tycińska,
Wojciech Wojakowski,
Katarzyna Buszko,
Robert Gil,
Marcin Gruchała,
Jarosław Kasprzak,
Andrzej Kleinrok,
Jacek Legutko,
Maciej Lesiak
and
Eliano P. Navarese
![]()
Cardiovascular disease and COVID-19: a position paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). (2021)
Edino Cenko,
L Badimon,
Raffaele Bugiardini,
Marc Claeys,
Giuseppe de Luca,
Cor de Wit,
Geneviève Derumeaux,
Maria Dorobantu,
Dirk Duncker,
Etto Eringa,
Diana Gorog,
Christian Hassager,
Frank Heinzel,
Kurt Huber,
Olivia Manfrini,
Davor Milicic,
Evangelos Oikonomou,
Teresa Padro,
Danijela Trifunovic-Zamaklar,
Zorana Vasilejevic-Pokrajcic
and
Marija Vavlukis
![]()
Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention? (2021)
Diana Gorog,
Eliano P Navarese
and
Felicita Andreotti
![]()
Spontaneous reperfusion in patients with transient ST-elevation myocardial infarction - prevalence, importance and approaches to management. (2021)
Mohamed Farag,
Marta Peverelli,
Nikolaos Spinthakis,
Ying X. Gue,
Mohaned Egred
and
Diana Gorog
![]()
A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study. (2021)
Jacek Kubica,
Piotr Adamski,
Piotr Niezgoda,
Aldona Kubica,
Przemysław Podhajski,
Malwina Barańska,
Julia M. Umińska,
Łukasz Pietrzykowski,
Małgorzata Ostrowska,
Jolanta M. Siller-Matula,
Jolita Badarienė,
Stanisław Bartuś,
Andrzej Budaj,
Sławomir Dobrzycki,
Łukasz Fidor,
Mariusz Gąsior,
Jacek Gessek,
Marek Gierlotka,
Robert Gil,
Jarosław Gorący,
Paweł Grzelakowski,
Tomasz Hajdukiewicz,
Miłosz Jaguszewski,
Marianna Janion,
Jarosław Kasprzak,
Adam Kern,
Artur Klecha,
Andrzej Kleinrok,
Wacław Kochman,
Bartosz Krakowiak,
Jacek Legutko,
Maciej Lesiak,
Marcin Nosal,
Grzegorz Piotrowski,
Andrzej Przybylski,
Tomasz Roleder,
Grzegorz Skonieczny,
Grzegorz Sobieszek,
Agnieszka Tycińska,
Dariusz Wojciechowski,
Wojciech Wojakowski,
Jarosław Wójcik,
Marzenna Zielińska,
Aleksander Żurakowski,
Giuseppe Specchia,
Diana A. Gorog
and
Eliano P. Navarese
![]()
Incidence of thrombotic complications in COVID-19. (2021)
William Jenner
and
Diana Gorog
![]()
Screening for venos thromboembolism in patient with COVID-19. (2021)
Christophe Vandenbriele
and
Diana Gorog
![]()
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: A systematic review and meta-analysis. (2021)
Eliano P Navarese,
Alexandra Lansky,
Dean Kereiakes,
Jacek Kubica,
Paul A Gurbel,
Diana Gorog,
Marco Valgimigli,
Nick Curzen,
David. E. Kandzari,
Marc Bonaca,
Marc Brouwer,
Julia M Umińska,
Milosz Jaguszewski,
Paolo Raggi,
Ron Waksman,
Martin B. Leon,
William Wijns
and
Felicita Andreotti
![]()
Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention. (2021)
Bhatt Deepak,
Juan Carlos Kaski,
Sean Delaney,
Mirvat Alasnag,
Felicita Andreotti,
Dominick J. Angiolillo,
Albert Ferro,
Diana Gorog,
Alberto Lorenzatti,
Mamas A. Mamas,
John McNeil,
José C Nicolau,
Gabriel Philippe Steg,
Juan Tamargo,
Tan Doreen
and
Marco Valgimigli
![]()
Optimal tests to minimise bleeding and ischaemic complications in patients on extracorporeal membrane oxygenation. (2021)
Rahim Kanji,
Christophe Vandenbriele,
Deepa R.J Arachchillage,
Susanna Price
and
Diana Gorog
![]()
Fibrinolysis in platelet thrombi. (2021)
Rahim Kanji,
Ying X. Gue,
Vassilios Memtsas
and
Diana Gorog
![]()
Assessment of endogenous fibrinolysis in clinical using novel tests - Ready for clinical roll-out? (2021)
Ying X. Gue,
Wern Yew Ding,
Gregory Y H Lip
and
Diana Gorog
![]()
Thrombotic complications in 2,928 patients with COVID-19 treated in intensive care: a systematic review. (2021)
William Jenner,
Rahim Kanji,
Saeed Mirsadraee,
Ying X. Gue,
Susanna Price,
Sanjay Prasad
and
Diana Gorog
![]()
Antithrombotic therapy in diabetes: Which, when, and for how long? (2021)
RA Ajjan,
N Kietsiriroje,
L Badimon,
Diana Gorog,
Dominick J. Angiolillo,
D Russel,
Bianca Rocca
and
Robert F. Storey
![]()
Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: A Pandora Box to Explain Prognostic Differences. (2021)
Hyun Kuk Kim,
Udaya S. Tantry,
Hyun-Woong Park,
Tobias Geisler,
Diana Gorog,
Paul A Gurbel
and
Young-Hoon Jeong
![]()
Non-Vitamin K Antagonist Oral Anticoagulants versus Warfarin for Patients with Left Ventricular Thrombus: A Systematic Review and Meta-analysis. (2021)
Ying X. Gue,
Nikolaos Spinthakis,
Mohaned Egred,
Diana Gorog
and
Mohamed Farag
![]()
Precision treatment in ACS – role of assessing fibrinolysis. (2021)
Ying X. Gue,
Young-Hoon Jeong,
Mohamed Farag,
Nikolaos Spinthakis
and
Diana Gorog
![]()
Role, laboratory assessment and clinical relevance of fibrin, factor XIII and endogenous fibrinolysis in arterial and venous thrombosis. (2021)
Vassilios Memtsas,
Deepa RJ Arachchillage
and
Diana Gorog
![]()
Prevalence of Thrombotic Complications in ICU-Treated Patients With Coronavirus Disease 2019 Detected With Systematic CT Scanning. (2021)
Saeed Mirsadraee,
Diana Gorog,
CF Mahon,
B Rawal,
TR Semple,
Ed Nicol,
Deepa RJ Arachchillage,
A Devaraj,
Price S,
SR Desai,
CA Ridge,
S Singh
and
SPG Padley
![]()
2020
Out-of-hospital cardiac arrest : A systematic review of current risk scores to predict survival. (2020)
Ying X. Gue,
Krishma ADATIA,
Rahim KANJI,
Tatjana POTPARA,
Gregory Y.H. LIP
and
Diana A. GOROG
![]()
Endogenous fibrinolysis - relevance to clinical thrombosis risk assessment. (2020)
Rahim Kanji,
Jacek Kubica,
Eliano P Navarese
and
Diana Gorog
![]()
Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19. (2020)
Ying X. Gue,
Maria Tennyson,
Jovia Gao,
Shuhui Ren,
Rahim Kanji
and
Diana A. Gorog
![]()
The East Asian Paradox : An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease. (2020)
Hyun Kuk Kim,
Udaya S. Tantry,
Sidney C. Smith,
Myung Ho Jeong,
Seung Jung Park,
Moo Hyun Kim,
Do Sun Lim,
Eun Seok Shin,
Duk Woo Park,
Yong Huo,
Shao Liang Chen,
Zheng Bo,
Shinya Goto,
Takeshi Kimura,
Satoshi Yasuda,
Wen Jone Chen,
Mark Chan,
Daniel Aradi,
Tobias Geisler,
Diana A. Gorog,
Dirk Sibbing,
Gregory Y.H. Lip,
Dominick J. Angiolillo,
Paul A. Gurbel
and
Young Hoon Jeong
![]()
2-oxothiazolidine-4-carboxylic acid inhibits vascular calcification via induction of glutathione synthesis. (2020)
Jessal Patel,
Lucie E Bourne,
Shori Thakur,
Kenneth Farrington,
Diana Gorog,
Isabel R Orriss
and
Anwar Baydoun
![]()
Aspirin related platelet reactivity as a determinant of ten year survival in high risk non-ST segment elevation myocardial infarction (NSTEMI) patients. (2020)
Nazish Khan,
Mamas A. Mamas,
Alexandra Moss,
Diana A. Gorog,
Peter Nightingale,
Angel Armesilla,
Andrew Smallwood,
Shahzad Munir,
Saib Khogali,
Ben Wrigley
and
James M. Cotton
![]()
Bioprosthetic valve thrombosis and degeneration following transcatheter aortic valve implantation (TAVI). (2020)
Saeed Mirsadraee
and
Diana Gorog
![]()
Low-grade endotoxaemia and platelets : A deadly aggregation. (2020)
Luca Liberale
and
Diana A. Gorog
![]()
Low-grade endotoxemia and platelets: a deadly aggregation. (2020)
Luca Liberale
and
Diana Gorog
![]()
Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes. (2020)
Robert F. Storey,
Paul A. Gurbel,
Jurrien ten Berg,
Corine Bernaud,
George D. Dangas,
Jean Marie Frenoux,
Diana A. Gorog,
Abdel Hmissi,
Vijay Kunadian,
Stefan K. James,
Jean Francois Tanguay,
Henry Tran,
Dietmar Trenk,
Mike Ufer,
Pim van der Harst,
Arnoud W.J. Van't Hof
and
Dominick J. Angiolillo
![]()
Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19. (2020)
Ying Gue
and
Diana Gorog
![]()
Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome. (2020)
Wilbert Bor
and
Diana Gorog
![]()
Point-of-care Platelet Function Tests: Relevance to Arterial Thrombosis and Opportunities for Improvement. (2020)
Diana Gorog
and
Richard Becker
![]()
Angiotensin Converting Enzyme 2 may mediate disease severity in COVID-19. (2020)
Ying X. Gue,
Rahim Kanji
and
Diana Gorog
![]()
Peripartum cardiomyopathy- can the link between prolactin and PAI-1 provide a clue? (2020)
Diana Gorog
and
Gemma Vilahur
![]()
Usefulness of the NULL-PLEASE Score to predict 1 survival in out-of hospital cardiac arrest. (2020)
Ying Gue,
Max Sayers,
Benjamin Whitby,
Rahim Kanji,
Krishma Adatia,
Robert Smith,
William Davies,
Aris Perperoglou,
Tatjana Potpara,
Gregory Y H Lip
and
Diana Gorog
![]()
MINOCA presenting with STEMI- a review of incidence, aetiology, assessment and treatment. (2020)
Ying X. Gue,
Rahim Kanji,
Sabiha Gati
and
Diana Gorog
![]()
Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction- a substudy of the CONDI-2/ERIC4 PPCI randomised controlled trial. (2020)
Diana Gorog,
Mohamed Farag,
Nikolaos Spinthakis,
Derek M. Yellon,
Hans E Bøtker†,
Rajesh Kharbanda
and
Derek Hausenloy
![]()
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a Joint Position Paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2020)
Diana Gorog,
Susanna Price,
Dirk Sibbing,
Andreas Baumbach,
Davide Capodanno,
Bruna Gigante,
Sigrun Halvorsen,
Kurt Huber,
Maddalena Lettino,
Sergio Leonardi,
Joao Morais,
Andrea Rubboli,
Jolanta M Siller-Matula,
Robert F. Storey,
Pascal Vranckx
and
Bianca Rocca
![]()
Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention : A Meta-Analysis. (2020)
Ying Gue,
Nikolaos Spinthakis,
Mohamed Farag,
Jacek Kubica,
Jolanta M Siller-Matula,
Manivannan Srinivasan
and
Diana Gorog
![]()
Platelet inhibition in acute coronary syndrome and PCI: Insights from the past and present. (2020)
Diana Gorog
and
Tobias Geisler
![]()
2019
Fatal heart block from intentional yew tree (Taxus baccata) ingestion: a case report. (2019)
Natasha G,
Mark Chan,
Ying X. Gue
and
Diana Gorog
![]()
Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome. (2019)
Ying X Gue,
Rahim Kanji,
David M Wellsted,
Manivannan Srinivasan,
Solange Wyatt
and
Diana A Gorog
![]()
Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation. (2019)
Ying X. Gue,
Nobutaka Inoue,
Nikolaos Spinthakis,
Hiroyuki Takahara,
Kazunori Otsui,
Gregory Y H Lip
and
Diana Gorog
![]()
MINOCA presenting with STEMI – incidence, aetiology and outcome in a contemporaneous cohort. (2019)
Ying X. Gue,
Natasha Corballis,
Alisdair Ryding,
Juan Carlos Kaski
and
Diana Gorog
![]()
Relationship of platelet reactivity and inflammatory markers to recurrent adverse events in patients with ST-elevation myocardial infarction. (2019)
Krishma Adatia,
Mohamed Farag,
Ying X. Gue,
Manivannan Srinivasan
and
Diana Gorog
![]()
Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial. (2019)
Derek Hausenloy,
Rajesh Kharbanda,
Ulla Kristine Møller,
Manish Ramlall,
Jens Aarøe,
Robert Butler,
Heerajnarain Bulluck,
Tim Clayton,
Ali Dana,
Matthew Dodd,
Thomas Engstrom,
Richard Evans,
Jens Flensted Lassen,
Erika Christensen,
José Manuel Garcia-Ruiz,
Diana Gorog,
Jakob Hjort,
Richard Houghton,
Borja Ibanez,
Rosemary Knight,
Freddy K Lippert,
Jacob Lønborg,
Michael Maeng,
Dejan Milasinovic,
Ranjit More,
Jennifer M Nicholas,
Lisette O Jensen,
Alexander Perkins,
Nebojsa Radovanovic,
Roby Rakhit,
Jan Ravkilde,
Alisdair D Ryding,
Michael R Schmidt,
Ingun S Riddervold,
Henrik T Sørensen,,
Goran Stankovic,
Madhusudhan Varma,
Ian Webb,
Christian J Terkelsen,
John Greenwood,
Derek Yellon
and
Hans E Bøtker†
![]()
Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor? : JACC Review Topic of the Week. (2019)
Diana Gorog
and
Gregory Y H Lip
![]()
Apixaban Enhances Endogenous Fibrinolysis in Patients with Atrial Fibrillation. (2019)
Nikolaos Spinthakis,
Ying X. Gue,
Mohamed Farag,
Manivannan Srinivasan,
David Wellsted,
Gregory Y H Lip,
Deepa RJ Arachchillage
and
Diana Gorog
![]()
Impact of lipoprotein apheresis on thrombotic parameters in patients with refractory angina and raised lipoprotein(a) : Findings from a randomized controlled cross-over trial. (2019)
Tina Z. Khan,
Diana A. Gorog,
Deepa J. Arachchillage,
Josefin Ahnström,
Samantha Rhodes,
Jacqueline Donovan,
Winston Banya,
Alison Pottle,
Mahmoud Barbir
and
Dudley J. Pennell
![]()
Understanding the Effects of NOAC Combined with Antiplatelet Therapy on Clot Kinetics. (2019)
Diana Gorog
![]()
Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy—Current Evidence and Practice. (2019)
Tobias Geisler,
Rezo Jorbenadze,
Aron-Frederik Popov,
Karin L. Mueller,
Dominik Rath,
Michal Droppa,
Juergen Schreieck,
Peter Seizer,
Robert F. Storey,
Steen D. Kristensen,
Andrea Rubboli,
Diana Gorog,
Daniel Aradi,
Dirk Sibbing,
Kurt Huber,
Meinrad Gawaz
and
Jur Ten Berg
![]()
A case of repetitive myocardial infarction with unobstructed coronaries due to Churg-Strauss syndrome. (2019)
Ying X. Gue,
Sanjay Prasad,
David Isenberg
and
Diana A. Gorog
![]()
Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture. (2019)
Nikolaos Spinthakis,
Ying Gue,
Mohamed Farag,
Guogang Ren,
Manivannan Srinivasan,
Anwar Baydoun
and
Diana A Gorog
![]()
Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events : the RISK PPCI study. (2019)
Mohamed Farag,
Nikolaos Spinthakis,
Ying X. Gue,
Manivannan Srinivasan,
Keith Sullivan,
David Wellsted
and
Diana A. Gorog
![]()
2018
Metabolism of ticagrelor in patients with acute coronary syndromes. (2018)
Piotr Adamski,
Katarzyna Buszko,
Joanna Sikora,
Piotr Niezgoda,
Malwina Barańska,
Małgorzata Ostrowska,
Przemysław Paciorek,
Eliano P Navarese,
Diana Gorog
and
Jacek Kubica
![]()
Potentiation of thrombus instability: a contributory mechanism to the effectiveness of antithrombotic medications. (2018)
Diana Gorog
![]()
Morphine Analgesia Pre-PPCI Is Associated with Prothrombotic State, Reduced Spontaneous Reperfusion and Greater Infarct Size. (2018)
Mohamed Farag,
Nikolaos Spinthakis,
Manivannan Srinivasan,
Keith Sullivan,
David Wellsted
and
Diana A Gorog
![]()
A rare cause of myocardial infarction with non-obstructive coronary arteries-case report of ST-segment elevation myocardial infarction caused by a mediastinal mass. (2018)
Ying X. Gue,
Majid Anwar
and
Diana A. Gorog
![]()
More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions. (2018)
Nikolaos Spinthakis,
Mohamed Farag,
Bianca Rocca
and
Diana Gorog
![]()
Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice. (2018)
Kavitha Vimalesvaran,
Seth J Dockrill
and
Diana Gorog
![]()
Is there a role for oral triple therapy in patients with acute coronary syndromes without atrial fibrillation? (2018)
Nikolaos Spinthakis,
Mohamed Farag,
Zaki Akhtar
and
Diana Adrienne Gorog
![]()
2017
Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting : A meta-analysis of patients with left main coronary artery disease. (2017)
Nikolaos Spinthakis,
Mohamed Farag,
Diana A Gorog,
Abhiram Prasad,
Hamid Mahmood,
Ying Gue,
David Wellsted,
Ashraf Nabhan
and
Manivannan Srinivasan
![]()
Catheter ablation for AF improves global thrombotic profile and enhances fibrinolysis. (2017)
Maria Niespialowska-Steuden,
Vias Markides,
Mohamed Farag,
David Jones,
Wajid Hussain,
Tom Wong
and
Diana A Gorog
![]()
Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction : A prospective, observational, single-centre study. (2017)
Piotr Adamski,
Joanna Sikora,
Ewa Laskowska,
Katarzyna Buszko,
Małgorzata Ostrowska,
Julia M Umińska,
Adam Sikora,
Natalia Skibińska,
Przemysław Sobczak,
Urszula Adamska,
Danuta Rość,
Aldona Kubica,
Przemysław Paciorek,
Michał P Marszałł,
Eliano P Navarese,
Diana A Gorog
and
Jacek Kubica
![]()
Importance of endogenous fibrinolysis in platelet thrombus formation. (2017)
Ying X. Gue
and
Diana A. Gorog
![]()
Prevalence of obstructive coronary artery disease and prognosis in patients with stable symptoms and a zero-coronary calcium score. (2017)
Tarun K Mittal,
Alison Pottle,
Ed Nicol,
Mahmoud Barbir,
Ben Ariff,
Saeed Mirsadraee,
Michael Dubowitz,
Diana A Gorog,
Piers Clifford,
Soroosh Firoozan,
Robert Smith,
Simon Dubrey,
Harmeet Chana,
Jaymin Shah,
Nigel Stephens,
Christopher Travill,
Andrew Kelion,
Mini Pakkal
and
Adam Timmis
![]()
Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention. (2017)
Christos Christopoulos,
Mohamed Farag,
Keith Sullivan,
David Wellsted
and
Diana A Gorog
![]()
Nitrates for the Management of Acute Heart Failure Syndromes, A Systematic Review. (2017)
Mohamed Farag,
Ahmad Shoaib
and
Diana A Gorog
![]()
Allopurinol as a therapeutic option in cardiovascular disease. (2017)
Osita N Okafor,
K Farrington
and
Diana A Gorog
2016
Spontaneous Coronary Artery Dissection : The Phantom Menace. (2016)
Nikolaos Spinthakis,
Nada Abdulkareem,
Mohamed Farag
and
Diana A Gorog
![]()
Relative effects of different non-vitamin K antagonist oral anticoagulants on global thrombotic status in atrial fibrillation. (2016)
Mohamed Farag,
Maria Niespialowska-Steuden,
Osita Okafor,
Benjamin Artman,
Manivannan Srinivasan,
Arif Khan,
Keith Sullivan,
David Wellsted
and
Diana A Gorog
![]()
Use of bioresorbable vascular scaffold : a meta-analysis of patients with coronary artery disease. (2016)
Mohamed Farag,
Nikolaos Spinthakis,
Diana A Gorog,
Abhiram Prasad,
Keith Sullivan,
Zaki Akhtar,
Neville Kukreja
and
Manivannan Srinivasan
![]()
2015
Global Thrombosis Test - a possible monitoring system for the effects and safety of dabigatran. (2015)
Kazunori Otsui,
Diana A Gorog,
Junichiro Yamamoto,
Takayuki Yoshioka,
Sachiyo Iwata,
Atsushi Suzuki,
Toru Ozawa,
Asumi Takei
and
Nobutaka Inoue
![]()
Bivalirudin versus unfractionated heparin : a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes. (2015)
Mohamed Farag,
Diana A Gorog,
Abhiram Prasad
and
Manivannan Srinivasan
![]()
Adjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction : role of vorapaxar. (2015)
Mohamed Farag,
Hiten Patel
and
Diana A Gorog
![]()
Endogenous Fibrinolysis : An Important Mediator of Thrombus Formation and Cardiovascular Risk. (2015)
Osita N Okafor
and
Diana A Gorog
![]()
2014
PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease. (2014)
G. Rosser,
P. Tricoci,
D. Morrow,
C. Christopoulos,
M. Niespialowska-Steuden,
Robert Kozarski,
R. Wilcox
and
Diana Gorog
![]()
Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential. (2014)
Diana Gorog,
J. Yamamoto,
N. Inoue,
K. Otsui
and
H. Ishii